Boston Scientific
BSX
BSX
851 hedge funds and large institutions have $58B invested in Boston Scientific in 2019 Q4 according to their latest regulatory filings, with 154 funds opening new positions, 300 increasing their positions, 274 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
9% more repeat investments, than reductions
Existing positions increased: 300 | Existing positions reduced: 274
6% more call options, than puts
Call options by funds: $188M | Put options by funds: $176M
0.2% less ownership
Funds ownership: 92.19% → 91.99% (-0.2%)
Holders
851
Holding in Top 10
29
Calls
$188M
Puts
$176M
Top Buyers
| 1 | +$432M | |
| 2 | +$365M | |
| 3 | +$215M | |
| 4 |
DCP
DSM Capital Partners
Palm Beach Gardens,
Florida
|
+$103M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$76.6M |
Top Sellers
| 1 | -$781M | |
| 2 | -$480M | |
| 3 | -$237M | |
| 4 |
JP Morgan Chase
New York
|
-$102M |
| 5 |
FAM
Fred Alger Management
New York
|
-$97.4M |